New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
07:29 EDTPEP, BRK.A, NSRGY, KKellogg speculated as Berkshire target amid volatile trading, Bloomberg says
Kellogg (K) shares have surged over last week amid speculation the company may be a takeover target for Warren Buffett’s Berkshire Hathaway (BRK.A), said Bloomberg's "Real M&A" column, which noted that Kellogg fits the financial criteria for the types of acquisitions Buffet has made in the past. Kellogg could also appeal to another food company, like PepsiCo (PEP) or Nestle (NSRGY), the report added. Reference Link
News For A;PEP;NSRGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 2, 2015
15:57 EDTALabCorp to offer PD-L1 companion diagnostic
Subscribe for More Information
15:43 EDTAQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for KEYTRUDA
Subscribe for More Information
15:25 EDTAAgilent's Dako confirms FDA approval of NSCLC diagnostic
Dako, an Agilent Technologies (A) company and a worldwide provider of cancer diagnostics, announced the FDA approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer, or NSCLC, is likely to respond to a new form of treatment. The approval of PD-L1 IHC 22C3 pharmDx strengthens Dako's portfolio of companion diagnostics and the company's leadership position in developing and commercializing companion diagnostic products. Dako developed PD-L1 IHC 22C3 pharmDx in partnership with Merck (MRK), maker of the anti-PD-1 therapy Keytruda. The FDA approved PD-L1 IHC 22C3 pharmDx for use in the United States. Dako hopes to gain regulatory approval for the new diagnostic in Canada, Europe and other jurisdictions next year.
September 30, 2015
14:50 EDTPEPPepsiCo volatility elevated into Q3 and outlook
Subscribe for More Information
September 25, 2015
08:10 EDTPEPPepsiCo Q3 should mark earnings trough, says JPMorgan
JPMorgan analyst John Faucher expects PepsiCo's earnings to trough in Q3 as currency headwinds peak. Earnings growth acceleration and gross margin upside position the stock well heading into 2016, the analyst argues. He reiterates an Overweight rating on PepsiCo with a $110 price target.
06:48 EDTNSRGYCereal makers tweak recipes in emerging markets, WSJ says
Subscribe for More Information
September 24, 2015
17:04 EDTAMerck, Pfizer to collaborate with Agilent's Dako on Avelumab diagnostic
Subscribe for More Information
08:02 EDTPEPPepsiCo sustainability initiatives delivered $375M in cost savings since 2010
September 23, 2015
13:06 EDTNSRGYNestle, AC Immune partner to develop new test for Alzheimer's
Nestle's Institute of Health Sciences has entered into an agreement with biopharmaceutical company AC Immune to develop a new, minimally invasive method of diagnosing Alzheimer's disease in its initial stages. Through the partnership, scientists will use exclusive NIHS technology that can measure certain biomarkers in the blood associated with cognitive decline. Reference Link
09:18 EDTPEPPaulson Institute and CCPIT to co-host U.S.-China Business Roundtable
The Paulson Institute and the China Council for the Promotion of International Trade (CCPIT) provide an opportunity for U.S. and Chinese business leaders to discuss issues facing the two countries in a roundtable being held in Seattle, Washington on September 23.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use